The University of Oxford candidate, led by Sarah Gilbert, might be through human trials in September. AstraZeneca has lined up agreements to produce 2 billion doses. They have signed licensing deals with companies in the U.K, India and Brazil to mass produce at a low cost to make it available to the entire world.
This comes as a ray of hope while the entire world is in the middle of a pandemic. Whilst most developing countries having their healthcare overwhelmed and high mortality rates, a vaccine could be the only answer to end the pandemic.
We also found an insightful and in-depth article clearly explaining why Oxford is ahead of the race.
More deets on that here : https://www.bloomberg.com/news/features/2020-07-15/oxford-s-covid-19-vaccine-is-the-coronavirus-front-runner
